Pilot Study to Measure Lung Biopsy Diagnostic Yield Using Always On Electromagnetic Tip Tracked Devices (ALOSPNDY)

Veran Medical Technologies

Status and phase: Withdrawn; Phase 4

Conditions: Pulmonary Coin Lesion

Treatments: Procedure: Lung biopsy using Always On EM Tip Tracked Device

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT01389154

VMT-SPiN_01

Details and patient eligibility

About

The objective of the prospective, multi-center study is to evaluate the ease of use and effectiveness of the SPiN Drive Electromagnetic (EM) Tip Tracked Steerable Devices as a method of sampling subsegmental, less than 3.0 cm, lung lesions through the airway, and beyond the bronchus. Measures of diagnostic yield will be compared to the diagnostic yield of similar published historical controls using conventional bronchoscopy.

Full description

Always On EM Tip Tracked Steerable catheters and biopsy devices used with the Veran Medical Technologies system are Food and Durg Administration 510K approved for use in diagnostic pulmonary procedures to locate and sample subsegmental peripheral, less than 3.0 centimeter lung lesions or solitary pulmonary nodules(SPN).

Up to 20 subjects with radiographically confirmed peripheral lung lesions will be asked to participate in the study and proceed with informed consent. An interim analysis of the data will be conducted to determine the need to include an additional 10 patients to achieve statistically significant results at the ninety five percent confidence interval.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject provides informed consent
• Subject is older than 50 years of age with 50% of patients at least 65 years of age
• Patient has a minimum of 20 pack years
• Subject scheduled to undergo conventional bronchoscopy as part of their standard medical care
• Subject has radiographically confirmed sub-segmental peripheral < 3.0 cm lung lesions
• A negative pregnancy test in women of child-bearing potential
• Subject is willing and able to return for all required follow-up
• Subject is mentally capable of following study directions

Exclusion criteria

• Subject has pacemaker, implantable cardioverter, and/or defibrillator
• Subject has any disease or condition that interferes with safe completion of initial or follow-up assessments
• Pregnant or nursing female subjects, or female subjects of child bearing potential who refuse to take a pregnancy prior to their enrollment in this study
• Concurrent participation in another study involving investigational drugs or investigational medical devices
• Inability to read and understand the necessary study documents

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

0 participants in 1 patient group

Patients recommended for a lung biopsy.

Experimental group

Description:

Patients with a positive diagnosis of a peripheral, less than 3.0 centimeter lung lesion, recommended for bronchoscopic biopsy are eligible to be consented into the study.

Treatment:

Procedure: Lung biopsy using Always On EM Tip Tracked Device